Second World Ayurveda Congress (Theme: Ayurveda for the Future)—Inaugural Address: Part II

In November 2006, the Second World Ayurveda Congress was held at the University of Pune, often known as the ‘Oxford of the East’. For the Congress to be held alongside the University's hallowed halls speaks much for the progress, Ayurveda has made in recent decades, particularly as it was housed just behind the main University administration building, once the summer residence of British Viceroys, including Ayurveda's most ruthless persecutor, Lord Macaulay. The choice of Pune was particularly due to the University's Professor of Interdisciplinary Health Sciences Professor Bhushan Patwardhan, also an editorial board member of eCAM who did much to organize the event. The last 5 years, in particular, have seen a sea change in Ayurveda's national profile. India's ancient medical system has slowly grown through a long period of rehabilitation from the depressed state in which it was left at independence by British antipathy. Although over half British materia medica at the time were of South Asian origin, Ayureda's value as a source of national wealth and wisdom, and more importantly of genuine medical insight and expertise, have only recently come to be officially acknowledged by India's academic community. Today, leaders from the nation's medical and scientific communities are working to promote research and scientific understanding of Ayurveda in the most up to date terms. No one has done more to promote the new surge of scientific interest in Ayurveda than the Director-General of India's Council for Scientific and Industrial Research (CSIR) Dr R. A. Mashelkar. Beginning in 2003-2004, he started over 25 research programs at CSIR research institutes around India, under the aegis of his ‘Golden Triangle’ initiative. Not unnaturally, Professor Mashelkar was asked to deliver the Congress's inaugural address, and set the tone for the new collaboration between modern science and ancient wisdom. His speech has been divided into three parts, which will be printed in successive issues of eCAM, Volume 5. The following is an almost verbatim account of the first part—Editors.

[1]  E. Cooper CAM, eCAM, Bioprospecting: The 21st Century Pyramid , 2005, Evidence-based complementary and alternative medicine : eCAM.

[2]  C. Grundy,et al.  WHO Global Atlas of Traditional, Complementary and Alternative Medicine , 2005 .

[3]  I. Wilkinson The House Of Lords Select Committee for Science and Technology. Their report on complementary and alternative medicine and its implications for reflexology. . . , 2002, Complementary therapies in nursing & midwifery.

[4]  P. K. Mohan,et al.  Association of l-DOPA with recovery following Ayurveda medication in Parkinson’s disease , 2000, Journal of the Neurological Sciences.

[5]  G. Bodeker Traditional and Complementary Medicine in the Commonwealth: New Partnerships Planned with the Formal Health Sector; Meeting of Commonwealth Health Related NGOs , 1999 .

[6]  Roger B. Davis,et al.  Heavy metal content of ayurvedic herbal medicine products. , 2004, JAMA.

[7]  Alex Hankey,et al.  The scientific value of Ayurveda. , 2005, Journal of alternative and complementary medicine.

[8]  A. Grollman,et al.  Botanical medicines--the need for new regulations. , 2002, The New England journal of medicine.

[9]  H. Wagner,et al.  Economic and Medicinal Plant Research , 1988 .

[10]  S. Straus Herbal medicines--what's in the bottle? , 2002, The New England journal of medicine.

[11]  P. Lavin,et al.  Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis. , 2000, The Journal of rheumatology.

[12]  B. Singhal,et al.  Epidemiology and treatment of Parkinson's disease in India. , 2003, Parkinsonism & related disorders.

[13]  P. Dobkin,et al.  Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. , 2000, The Journal of rheumatology.

[14]  P. Lavin,et al.  A 32-Week Randomized, Placebo-Controlled Clinical Evaluation of RA-11, an Ayurvedic Drug, on Osteoarthritis of the Knees , 2004, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[15]  S. S. Kumar,et al.  Hepatoprotective activity of the Trikatu Churna: an Ayurvedic formulation , 2004 .

[16]  N. Bhatt,et al.  Ayurveda and Traditional Chinese Medicine: A Comparative Overview , 2005, Evidence-based complementary and alternative medicine : eCAM.

[17]  C. Arvind,et al.  Classification of human population based on HLA gene polymorphism and the concept of Prakriti in Ayurveda. , 2005, Journal of alternative and complementary medicine.

[18]  H. Lee,et al.  New findings of the correlation between acupoints and corresponding brain cortices using functional MRI. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Gupta,et al.  Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. , 1998, European Journal of Medical Research.

[20]  Edwin L. Cooper On the Road to an Impact Factor for eCAM , 2007, Evidence-based complementary and alternative medicine : eCAM.

[21]  M. Dharmalingam,et al.  Evaluation of Clinical Efficacy of Diabecon with Reference to Insulin- Levels in Diabetic Patients , 2002 .